The aim of the cooperation is to support the educational and therapeutic work with children with autism by using ABA DrOmnibus App to improve the effectiveness of ABA therapy.
DrOmnibus invites Partners, institutions, and BCBA therapists, to improve the effectiveness of ABA Therapy by using the ABA APP. Meet the first Partner – Eden II Programs.
About Eden II Programs
In February 2018 DrOmnibus started cooperation with Eden II Programs.
Eden II Program is the not-for-profit organization serves over 500 participants in New York City and Long Island. The mission of Eden II Programs is to support people with autism. They provide it through service, science, and passion, so people with autism may achieve their full potential throughout their lives. Eden II Programs provides a variety of services using the evidence-based principles of applied behavior analysis (ABA). Eden II is recognized nationally as a leader in working with individuals across the autism spectrum, including those with the most significant challenges.
The aim of the cooperation
The aim of the cooperation is to support the educational and therapeutic work with children with autism by using ABA DrOmnibus App to improve the effectiveness of ABA Therapy. ABA DrOmnibus App is a multimedia tool that complements ABA therapy. The APP includes resources for therapy and allows you to continue therapy at home. ABA Dromnibus App has been designed to teach essential skills to children with autism and help them develop better and is easily adapted for therapy at a clinic (institutions) and at home.
DrOmnibus will develop a tool for BCBA thanks to ideas and comments from ABA therapists form Eden II and parents of children with autism.
The project will involve 8 therapists and 3 parents of children from Eden II programs who will share their opinions with DrOmnibus every month and describe the progress of children with autism that will use the ABA DrOmnibus application in the institution and at home.
Soon, the first materials about our cooperation with Eden II Programs.
Read more about our Partners :